US Patent 7148211 Formulation for lipophilic agents
Patent 7148211 was granted and assigned to Genzyme on December, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 9 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Creighton Reed Goldensoph0
Jeffrey W. Driscoll0
Leon W. LeVan0
Richard B. Mazess0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+214 characters)
Article
Patent abstract
The invention relates to pharmaceutical formulations of lipophilic therapeutic agents in which such agents are solubilized in largely aqueous vehicles, and processes for preparing and using the same.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07148211 Formulation for lipophilic agents US Patent 7148211 Formulation for lipophilic agents
Infobox
Patent Number
07148211
Patent Number
7148211
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07148211 Formulation for lipophilic agents
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07148211
Date of patent
December 12, 2006
Patent application number
10247765
Date Filed
September 18, 2002
Patent primary examiner
Find more entities like US Patent 7148211 Formulation for lipophilic agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.